C. Morimoto et al., ROLE OF CD26 DIPEPTIDYL PEPTIDASE-IV IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION AND APOPTOSIS/, Proceedings of the National Academy of Sciences of the United Statesof America, 91(21), 1994, pp. 9960-9964
To examine the role of CD26/dipeptidyl peptidase IV (DPPIV; EC 3.4.14.
5) in infection by human immunodeficiency virus type 1 (HIV-1), we uti
lized CD26 cDNA-transfected Jurkat T-cell lines. Both CD26(-) parental
Jurkat cells and mutant CD26(+) (DPPIV-) transfected Jurkat cells wer
e readily infected with HIV-1, whereas wild-type CD26(+) (DPPIV+) tran
sfected Jurkat cells were more resistant to HIV-1 infection. Our resul
ts suggest that CD26 is not essential for HIV-1 infectivity as suggest
ed by others but that DPPIV enzyme activity may decrease the efficienc
y of HIV-1 infection, Of great interest, we found that mutant CD26(+)
(DPPIV-) transfectants and CD26(-) parental Jurkat cells strongly expr
essed CD95 (Fas/Apo-1) and were more sensitive than wild-type CD26(+)
(DPPIV+) transfectants to the induction of apoptosis by anti-CD95 mono
clonal antibody. These results suggest that CD26 may play a role in HI
V-1-associated loss of CD4(+) cells through the process of programmed
cell death.